Loading clinical trials...
Loading clinical trials...
To investigate the immunogenicity of HB vaccine with different series among primary immune adults aged 25-55, to assess potential alternative approaches for HB immunization.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Wu Jiang
NCT06067555 · Vaccine Reaction
NCT05923333 · Hiv, Vaccine Reaction, and more
NCT05115617 · SARS-CoV2 Infection, Covid19, and more
NCT05825651 · Long COVID, COVID-19 Pandemic, and more
NCT05431933 · Poliomyelitis, Vaccine Reaction
Huaibei District Center for Disease Control and Prevention
Huaibei, Anhui
Xuanhua District Center for Disease Control and Prevention
Xuanhua, Hebei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions